Trx1-CA125 strategy matches ROMA with higher ovarian cancer sensitivity
An exploratory diagnostic study found that combining Trx1 and CA125 produced higher reported ovarian cancer sensitivity than ROMA overall, in ...
An exploratory diagnostic study found that combining Trx1 and CA125 produced higher reported ovarian cancer sensitivity than ROMA overall, in ...
